State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, China.
Gut. 2022 Nov;71(11):2325-2336. doi: 10.1136/gutjnl-2021-325018. Epub 2022 Jan 7.
Liver regeneration remains one of the biggest clinical challenges. Here, we aim to transform the spleen into a liver-like organ via directly reprogramming the splenic fibroblasts into hepatocytes in vivo.
In the mouse spleen, the number of fibroblasts was through silica particles (SiO) stimulation, the expanded fibroblasts were converted to hepatocytes (iHeps) by lentiviral transfection of three key transcriptional factors (Foxa3, Gata4 and Hnf1a), and the iHeps were further expanded with tumour necrosis factor-α (TNF-α) and lentivirus-mediated expression of epidermal growth factor (EGF) and hepatocyte growth factor (HGF).
SiO stimulation tripled the number of activated fibroblasts. Foxa3, Gata4 and Hnf1a converted SiO-remodelled spleen fibroblasts into 2×10 functional iHeps in one spleen. TNF-α protein and lentivirus-mediated expression of EGF and HGF further enabled the total hepatocytes to expand to 8×10 per spleen. iHeps possessed hepatic functions-such as glycogen storage, lipid accumulation and drug metabolism-and performed fundamental liver functions to improve the survival rate of mice with 90% hepatectomy.
Direct conversion of the spleen into a liver-like organ, without cell or tissue transplantation, establishes fundamental hepatic functions in mice, suggesting its potential value for the treatment of end-stage liver diseases.
肝脏再生仍然是最大的临床挑战之一。在这里,我们旨在通过直接将脾成纤维细胞重编程为体内肝细胞来将脾脏转化为肝样器官。
在小鼠脾脏中,通过二氧化硅颗粒(SiO)刺激来增加成纤维细胞的数量,通过慢病毒转染三种关键转录因子(Foxa3、Gata4 和 Hnf1a)将扩增的成纤维细胞转化为肝细胞(iHeps),并进一步用肿瘤坏死因子-α(TNF-α)和慢病毒介导的表皮生长因子(EGF)和肝细胞生长因子(HGF)表达来扩增 iHeps。
SiO 刺激使激活的成纤维细胞数量增加了两倍。Foxa3、Gata4 和 Hnf1a 将 SiO 重塑的脾成纤维细胞转化为一个脾脏中的 2×10 个功能性 iHeps。TNF-α 蛋白和慢病毒介导的 EGF 和 HGF 的表达进一步使总肝细胞扩增到每个脾脏 8×10。iHeps 具有肝功能,如糖原储存、脂质积累和药物代谢,并发挥基本的肝脏功能,提高 90%肝切除术小鼠的存活率。
无需细胞或组织移植,将脾脏直接转化为肝样器官,在小鼠中建立了基本的肝脏功能,这表明其在治疗终末期肝病方面具有潜在价值。